COMMODORE CAPITAL LP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
COMMODORE CAPITAL LP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2022$43,297,000
+23.3%
893,6460.0%6.96%
-6.2%
Q2 2022$35,111,000
+11.6%
893,646
+4.6%
7.42%
+5.6%
Q1 2022$31,460,000
-2.0%
854,652
+21.3%
7.03%
-5.5%
Q4 2021$32,113,000
+12.8%
704,537
-11.6%
7.44%
-0.9%
Q3 2021$28,470,000
+104.3%
796,578
+13.1%
7.51%
+54.6%
Q2 2021$13,938,000704,3174.86%
Other shareholders
CYTOKINETICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders